A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease

NCT00679627 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
2051
Enrollment
INDUSTRY
Sponsor class

Stopped Due to a pre-specified imbalance of deaths between treatment groups, the DSMB recommended early termination of the trial

Conditions

Interventions

Sponsor

Janssen Research & Development, LLC